The market of APAC POCT Device Market is expected to reach USD 4.66 bin 2016, at a CAGR of 9.2% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
Access Full Report: https://www.databridgemarketresearch.com/reports/apac-point-care-testing-poct-market
Segmentation: APAC POCT Device Market
By Product Type {Blood Glucose Testing Kits, Cardiometabolic Monitoring Kits(Cardiac Markers, Blood Gas/Electrolytes Testing Kits, HbA1c Testing Kits, Lipids Testing), Infectious Disease Testing Kits(Influenza Testing Kits, HIV Testing Kits, Hepatitis C Testing Kits, Sexually Transmitted Diseases (STDs) Testing Kits, Tropical Diseases Testing Kits, Healthcare-Associated Infection Testing Kits, Respiratory Infections Testing Kits),Cholesterol Testing Kits(PT/INR Testing Kits, Activated Clotting Time (ACT/APTT) Testing Kits), Pregnancy & Fertility Tests Kits, Tumor/Cancer Markers, Urinalysis Testing Kits, Hematology Testing Kits, Drugs Of Abuse Testing Kits, Fecal Occult Testing Kits, Rapid Coagulation Testing Kits}, Prescription Mode (Prescription Based Testing, Over-The-Counter Testing), Distribution Channel (Direct Tenders, Retail), End User (Hospitals, Clinics, Home Ambulatory Care, Home Healthcare,Research Laboratory), Geography (Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines and rest of APAC)
Drivers: APAC POCT Device Market
Some of the major factors driving the APAC POCT device market are rising prevalence of lifestyle, advancement in technology, increase in chronic and infectious diseases, scope for unmet medical needs, and emerging POCT device market. These factors increase the demand for devices such as blood glucose meter, CRP, HBA1c, homocystein.
RISING PREVALENCE OF LIFESTYLE
In recent times, people with their hectic schedule and changing lifestyle such as daily working schedules even for women, eating habits, rapid growth in population, rise in smoking and drinking habits, obesity disorders and many more has led to the demand for early treatment which results in driving the growth of POCT device in market.
INCREASE IN CHRONIC AND INFECTIOUS DISEASES
The prevalence of chronic diseases (cardiovascular diseases, hypertension, obesity, hepatitis, cancer, diabetes mellitus and many others) across the globe has increased considerably over a period of time. The rapidly increasing aging population and the subsequent rise in chronic conditions are major factors driving the demand for APAC POCT device market.
ADVANCEMENTS IN TECHNOLOGY
The APAC POCT device market is expected to show significant growth in the coming years, due to various technological advancements and new product launches in order to enhance safety and results through quick testing with reliable and noteworthy outcomeswith reduced sample volume or less blood on portable devices.
Major Players: APAC POCT Device Market
Some of the Major Players Operating in this Market are:-
- Abbott,
- Alere Inc.,
- F. Hoffmann La Roche Diagnostics Limited,
- Siemens AG,
- Becton,
- Dickinson and Company,
- Johnson & Johnson Services Inc.,
- PTS Diagnostics,
- Instrumentation Laboratory,
- Nova Biomedical,
- Beckman Coulter, Inc. and others.
